Author
Listed:
- Eric Letouzé
(Equipe Labellisée Ligue Contre le Cancer, Institut Universitaire d’Hématologie
Université Paris Descartes, Labex Immuno-Oncology, Sorbonne Paris Cité, Faculté de Médecine
Université Paris 13, Sorbonne Paris Cité, Unité de Formation et de Recherche Santé, Médecine, Biologie Humaine
Université Paris Diderot)
- Jayendra Shinde
(Equipe Labellisée Ligue Contre le Cancer, Institut Universitaire d’Hématologie
Université Paris Descartes, Labex Immuno-Oncology, Sorbonne Paris Cité, Faculté de Médecine
Université Paris 13, Sorbonne Paris Cité, Unité de Formation et de Recherche Santé, Médecine, Biologie Humaine
Université Paris Diderot)
- Victor Renault
(Fondation Jean Dausset—CEPH)
- Gabrielle Couchy
(Equipe Labellisée Ligue Contre le Cancer, Institut Universitaire d’Hématologie
Université Paris Descartes, Labex Immuno-Oncology, Sorbonne Paris Cité, Faculté de Médecine
Université Paris 13, Sorbonne Paris Cité, Unité de Formation et de Recherche Santé, Médecine, Biologie Humaine
Université Paris Diderot)
- Jean-Frédéric Blanc
(Université Bordeaux, Bordeaux Research in Translational Oncology
Centre Medico-Chirurgical Magellan, Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux)
- Emmanuel Tubacher
(Fondation Jean Dausset—CEPH)
- Quentin Bayard
(Equipe Labellisée Ligue Contre le Cancer, Institut Universitaire d’Hématologie
Université Paris Descartes, Labex Immuno-Oncology, Sorbonne Paris Cité, Faculté de Médecine
Université Paris 13, Sorbonne Paris Cité, Unité de Formation et de Recherche Santé, Médecine, Biologie Humaine
Université Paris Diderot)
- Delphine Bacq
(Centre National de Recherche en Génomique Humaine, CEA)
- Vincent Meyer
(Centre National de Recherche en Génomique Humaine, CEA)
- Jérémy Semhoun
(Fondation Jean Dausset—CEPH)
- Paulette Bioulac-Sage
(Université Bordeaux, Bordeaux Research in Translational Oncology
Hôpital Pellegrin, Centre Hospitalier Universitaire de Bordeaux)
- Sophie Prévôt
(AP-HP, Hôpital Antoine-Béclère, Service d’anatomie pathologique)
- Daniel Azoulay
(Université Paris Est Créteil
AP-HP, Groupe Hospitalier Henri Mondor, Département de Chirurgie Hépato-Biliaire et Transplantation Hépatique)
- Valérie Paradis
(Service d’Anatomopathologie, Hôpital Beaujon)
- Sandrine Imbeaud
(Equipe Labellisée Ligue Contre le Cancer, Institut Universitaire d’Hématologie
Université Paris Descartes, Labex Immuno-Oncology, Sorbonne Paris Cité, Faculté de Médecine
Université Paris 13, Sorbonne Paris Cité, Unité de Formation et de Recherche Santé, Médecine, Biologie Humaine
Université Paris Diderot)
- Jean-François Deleuze
(Centre National de Recherche en Génomique Humaine, CEA)
- Jessica Zucman-Rossi
(Equipe Labellisée Ligue Contre le Cancer, Institut Universitaire d’Hématologie
Université Paris Descartes, Labex Immuno-Oncology, Sorbonne Paris Cité, Faculté de Médecine
Université Paris 13, Sorbonne Paris Cité, Unité de Formation et de Recherche Santé, Médecine, Biologie Humaine
Université Paris Diderot)
Abstract
Genomic alterations driving tumorigenesis result from the interaction of environmental exposures and endogenous cellular processes. With a diversity of risk factors, liver cancer is an ideal model to study these interactions. Here, we analyze the whole genomes of 44 new and 264 published liver cancers and we identify 10 mutational and 6 structural rearrangement signatures showing distinct relationships with environmental exposures, replication, transcription, and driver genes. The liver cancer-specific signature 16, associated with alcohol, displays a unique feature of transcription-coupled damage and is the main source of CTNNB1 mutations. Flood of insertions/deletions (indels) are identified in very highly expressed hepato-specific genes, likely resulting from replication-transcription collisions. Reconstruction of sub-clonal architecture reveals mutational signature evolution during tumor development exemplified by the vanishing of aflatoxin B1 signature in African migrants. Finally, chromosome duplications occur late and may represent rate-limiting events in tumorigenesis. These findings shed new light on the natural history of liver cancers.
Suggested Citation
Eric Letouzé & Jayendra Shinde & Victor Renault & Gabrielle Couchy & Jean-Frédéric Blanc & Emmanuel Tubacher & Quentin Bayard & Delphine Bacq & Vincent Meyer & Jérémy Semhoun & Paulette Bioulac-Sage &, 2017.
"Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis,"
Nature Communications, Nature, vol. 8(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-01358-x
DOI: 10.1038/s41467-017-01358-x
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-01358-x. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.